Understanding Your Diagnosis: CARD9 Deficiency
At a Glance
CARD9 deficiency is a rare inherited immune condition that mainly weakens the body's defense against certain fungi. It can lead to severe or recurrent infections of the skin, nails, lymph nodes, or brain, while some people with the condition remain symptom-free.
Finding out you or a loved one has a CARD9 deficiency can be overwhelming, especially because it is a rare and highly specific condition, often termed an “inborn error of immunity.” Unlike many other immune disorders that make people vulnerable to all sorts of bacteria and viruses, a CARD9 deficiency is a “narrow” or specific immune defect [1]. Most people with this condition are otherwise healthy and fight off common colds or flu just like anyone else; their immune system simply has a specific vulnerability or “blind spot” when it comes to certain types of fungi [2].
What is CARD9?
CARD9 (Caspase Recruitment Domain-containing protein 9) is a vital protein that acts like a bridge in your immune system’s communication network [3]. Its primary job is to pass along “danger signals” from the surface of your immune cells to the internal machinery that launches an attack against fungi [4].
When your body detects a fungus, specialized sensors called C-type lectin receptors (CLRs) pick up the scent [3]. These sensors rely on the CARD9 protein to send a signal into the cell to start producing protective chemicals. In a person with this deficiency, that bridge is broken. The sensors may “see” the fungus, but the message to fight back may never reach its destination [3][4].
The Biological “Blind Spot”
Because the CARD9 bridge is missing or malfunctioning, the immune system can fail to respond in three critical ways:
- Poor Chemical Response: The body may fail to produce enough inflammatory cytokines—messenger chemicals like TNF-alpha, IL-6, and IL-1-beta [1][5]. These chemicals are supposed to sound the alarm and coordinate the immune response.
- Failure of Neutrophil Recruitment: One of the most important responders in the immune system is the neutrophil, a type of white blood cell that eats and kills fungi [6]. In CARD9 deficiency, the body may have plenty of neutrophils circulating in the blood, but they might not get the signal to move into the infected tissue (like the brain or skin) where the fungus is growing [7][8].
- Low Th17 Cells: Many (though not all) patients have lower levels of Th17 cells, a specific type of T-cell that is a specialist in fighting fungal and bacterial infections on the skin and mucous membranes [9][1].
How It Is Inherited
CARD9 deficiency is an autosomal recessive condition [1]. This means a person must inherit two copies of the mutated gene (biallelic variants)—one from each parent—to have the deficiency [10].
- Carriers: Parents usually have one normal gene and one mutated gene. They are “carriers” and typically have no symptoms and no increased risk of fungal infections.
- The 25% Rule: If both parents are carriers, there is a 25% chance with each pregnancy that the child will inherit both mutated genes and have CARD9 deficiency. There is a 50% chance the child will be a carrier, and a 25% chance they will be unaffected.
Variable Onset and Penetrance
One of the most confusing aspects of this condition is its “variable penetrance.” This means that even if two people have the exact same genetic mutation, their experiences can be very different [1].
- Age of Onset: Fungal infections can start at almost any time. While one large review of affected patients found many cases are discovered in childhood or adolescence (around 58% of cases), others do not show symptoms until late adulthood. Reported ages of first infection range from 1 year to 91 years old [11][12]. Note that these numbers come from selected rare-disease reports and do not predict your personal likelihood or timeline of becoming ill.
- Asymptomatic Relatives: It is possible for someone to have both mutated genes but never actually get sick [10]. These individuals are “asymptomatic.” Because of this, doctors often recommend testing siblings and close relatives of a diagnosed patient, even if those relatives feel perfectly healthy [1][10].
Common Fungal Targets
Because the immune system is specifically weak against fungi, patients are at risk for several types of infections that would rarely bother a person with a typical immune system:
- CNS Candidiasis: Candida (a type of yeast) can invade the central nervous system (the brain and spinal cord), causing serious illness [1][12].
- Deep Dermatophytosis: This is a severe, deep-seated infection caused by the same fungi that cause athlete’s foot or ringworm. Instead of staying on the surface of the skin, the fungus moves deep into the skin, nails, or even lymph nodes [1][11].
- Phaeohyphomycosis: Infections caused by certain “molds” or dark-pigmented fungi that can cause skin lesions or internal infections [1][8].
It is important to remember that while these infections can be severe and tend to recur, they are treatable. Diagnosis is the first step in ensuring you receive the specific, long-term monitoring and care needed to manage this unique immune profile [13].
Common questions in this guide
What is CARD9 deficiency?
Why does CARD9 deficiency increase the risk of fungal infections?
Which fungal infections can occur with CARD9 deficiency?
How is CARD9 deficiency inherited?
Can someone have CARD9 deficiency without symptoms?
Should relatives be tested for CARD9 deficiency even if they feel healthy?
Get notified when new evidence is published on Predisposition to invasive fungal disease due to CARD9 deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults.
Corvilain E, Casanova JL, Puel A
Journal of clinical immunology 2018; (38(6)):656-693 doi:10.1007/s10875-018-0539-2.
PMID: 30136218 - 2
Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.
Pérez de Diego R, Sánchez-Ramón S, López-Collazo E, et al.
The Journal of allergy and clinical immunology 2015; (136(5)):1139-49.
PMID: 26277595 - 3
Mechanistic Insights into the Role of C-Type Lectin Receptor/CARD9 Signaling in Human Antifungal Immunity.
Drummond RA, Lionakis MS
Frontiers in cellular and infection microbiology 2016; (6()):39 doi:10.3389/fcimb.2016.00039.
PMID: 27092298 - 4
A CARD9 Founder Mutation Disrupts NF-κB Signaling by Inhibiting BCL10 and MALT1 Recruitment and Signalosome Formation.
De Bruyne M, Hoste L, Bogaert DJ, et al.
Frontiers in immunology 2018; (9()):2366 doi:10.3389/fimmu.2018.02366.
PMID: 30429846 - 5
Impairment of Immune Response against Dematiaceous Fungi in Card9 Knockout Mice.
Wu W, Zhang R, Wang X, et al.
Mycopathologia 2016; (181(9-10)):631-42 doi:10.1007/s11046-016-0029-0.
PMID: 27421992 - 6
CARD9+ microglia promote antifungal immunity via IL-1β- and CXCL1-mediated neutrophil recruitment.
Drummond RA, Swamydas M, Oikonomou V, et al.
Nature immunology 2019; (20(5)):559-570 doi:10.1038/s41590-019-0377-2.
PMID: 30996332 - 7
CARD9-Dependent Neutrophil Recruitment Protects against Fungal Invasion of the Central Nervous System.
Drummond RA, Collar AL, Swamydas M, et al.
PLoS pathogens 2015; (11(12)):e1005293 doi:10.1371/journal.ppat.1005293.
PMID: 26679537 - 8
Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.
Rieber N, Gazendam RP, Freeman AF, et al.
JCI insight 2016; (1(17)):e89890.
PMID: 27777981 - 9
Inherited human CARD9 deficiency impairs lymphoid cell, but not fibroblast, IL-17-mediated immunity.
Della Mina E, El-Haddad CG, West TA, et al.
JCI insight 2026; (11(8)).
PMID: 42018653 - 10
Inherited CARD9 Deficiency in a Child with Invasive Disease Due to Exophiala dermatitidis and Two Older but Asymptomatic Siblings.
Imanaka Y, Taniguchi M, Doi T, et al.
Journal of clinical immunology 2021; (41(5)):975-986 doi:10.1007/s10875-021-00988-7.
PMID: 33558980 - 11
Clinical features of patients with fungal infections caused by CARD9 deficiency: a literature review of case reports.
Tang C, Liu Y, Long J, Lv X
Frontiers in cellular and infection microbiology 2025; (15()):1615929 doi:10.3389/fcimb.2025.1615929.
PMID: 40740345 - 12
Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians.
Gavino C, Hamel N, Zeng JB, et al.
The Journal of allergy and clinical immunology 2016; (137(4)):1178-1188.e7 doi:10.1016/j.jaci.2015.09.016.
PMID: 26521038 - 13
Successful Allogenic Stem Cell Transplantation in Patients with Inherited CARD9 Deficiency.
Queiroz-Telles F, Mercier T, Maertens J, et al.
Journal of clinical immunology 2019; (39(5)):462-469 doi:10.1007/s10875-019-00662-z.
PMID: 31222666
This page is for informational purposes only and does not constitute medical advice. Discuss CARD9 testing, fungal-infection monitoring, and family screening with your immunologist or another qualified healthcare professional.